(166 days)
Not Found
No
The summary describes a standard ultrasonic imaging device with a digital scan converter and video monitor. There is no mention of AI, ML, or advanced image processing techniques that would typically indicate the presence of such technology. The description focuses on the hardware and basic imaging capabilities.
No
This device is for ultrasonic imaging and measurement, enabling visualization of anatomical structures. It does not mention any therapeutic function or intervention.
No
Explanation: The device is described as an "ultrasonotomograph" for "imaging and measurement" of anatomical structures and for making "images to be observable on a video monitor." This suggests the device is used for capturing images or measurements of the body, which are then used by a healthcare professional to form a diagnosis. The device itself does not appear to provide a diagnosis or diagnostic output.
No
The device description explicitly states it is a "linear/convex electronic scanning ultrasonotomograph with a built-in digital scan converter (DSC)" and is a "portable" "main unit" that can be used with a "video monitor" and "special photographic unit." This indicates it is a hardware device that performs ultrasonic imaging.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. These tests are performed outside of the body.
- Device Function: The description clearly states that this device uses "Ultrasonic pulsed echo imaging" to create images of internal organs and structures. This is a form of in vivo imaging, meaning it is performed inside the body.
- Intended Use: The intended use is for imaging and measurement of various anatomical sites within the body. This is consistent with an imaging device, not a diagnostic test performed on a sample.
Therefore, based on the provided information, this device is an ultrasound imaging system, not an IVD.
N/A
Intended Use / Indications for Use
Ultrasonic pulsed echo imaging and measurement for fetal imaging and other abdominal as well as pediatric, small organ, neonatal cephalic, adult cephalic, and heart.
Product codes (comma separated list FDA assigned to the subject device)
90 IYO
Device Description
Model CTS-310B is a linear/convex electronic scanning ultrasonotomograph with a built-in digital scan converter (DSC). The unit allows heart, abdominal organic and fetal tomographic images to be observable on a video monitor. The main unit is portable and is separable from other equipment to be carried for its use at another place as well as being usable in combination with a 9-inch video monitor and a special photographic unit.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic Pulsed Echo Imaging System
Anatomical Site
Fetal, Abdominal, Pediatric, Small Organ (thyroid gland, breast, testes), Neonatal Cephalic, Adult Cephalic, Cardiac.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Hitachi Medical Corporation EUB-310, K862867
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
KG84161
韶声仪器研究
5 1999 MAY
Tab 11
Premarket Notification [510(k)] Summary
September 7,1998
CTS-310B with EZU-PL12 and EZU-PC3A Transducers Trade Name:
Diagnostic Ultrasound System Common Name:
Ultrasonic Pulsed Echo Imaging System, 90 IYO Classification Name:
(per 21 CFR section 892.1560)
Shantou Institute of Ultrasonic Instruments
Manufacturer's Name:
Address:
Shantou Sez, 515041, China
#2, Jinsha Road, M.,
Corresponding Official: Mr. Jinzhong Yao
Title: President
Fax: (86) 754-8251499 Telephone: (86) 754-8250150
Predicate: Hitachi Medical Corporation EUB-310, K862867
Device Description: Model CTS-310B is a linear/convex electronic scanning ultrasonotomograph with a built-in digital scan converter (DSC). The unit allows heart, abdominal organic and fetal tomographic images to be observable on a video monitor. The main unit is portable and is separable from other equipment to be carried for its use at another place as well as being usable in combination with a 9-inch video monitor and a special photographic unit.
Intended Use: Ultrasonic pulsed echo imaging and measurement for fetal imaging and other abdominal as well as pediatric, small organ, neonatal cephalic, adult cephalic, and heart.
Technological Characteristics: See the attached "Comparison List" of the SIUI CTS-310B and the Hitachi EUB-310.
1
COMPARIS ON LIST OF SIUI PRODUCT AND HITACHI PRODUCT
Performance | CTS-310 (SIUI) | EUB-310A (HITACHI) | |
---|---|---|---|
main | |||
unit | scanning | ||
mode | electronic linear scanning | ||
(compatible 80 elements linear probe) electronic convex sector | |||
(compatible convex probe of 80 elements) | electronic linear scanning | ||
(compatible 80 elements linear probe) electronic convex sector | |||
(compatible convex probe of 80 elements) | |||
display mode | B mode B/B ode, M mode, B/M mode | ||
simultaneously | B mode, B/B mode, M mode, B/M | ||
mode simultaneously | |||
measure- | |||
ment | in B mode display: distance, area | ||
and circumference | |||
in M mode display: time interval, | |||
velocity, depth and heart rate | in B mode display: distance, area | ||
and circumference | |||
in M mode display: time interval, | |||
velocity, depth and heart rate | |||
calculation | area, circumference, volume, heart | ||
rate, pregnant weeks and heart | |||
function | area, circumference, volume, heart | ||
rate, pregnant weeks and heart | |||
function | |||
focusing | |||
mode | 4-steps dynamic focusing with | ||
variable aperture and lens focusing | 4-steps dynamic focusing with | ||
variable aperture and lens focusing | |||
scanning | |||
width | linear scanning: 3.5MHz probe | ||
104mm, 5MHz probe 61mm | |||
convex sector scanning probe: | |||
sector angle 60° | linear scanning: 3.5MHz probe | ||
104mm, 5MHz probe 61mm | |||
convex sector scanning probe: | |||
sector angle 60° | |||
transmitting | |||
voltage | pulse height 130V | pulse height 130V | |
transmitting | |||
pulse width | 3.5MHz pulse width 140 μs | ||
5MHz pulse width 100 μs | 3.5MHz pulse width 140 μs | ||
5MHz pulse width 100 μs | |||
detecting | |||
depth | 3.5MHz probe maximum depth: | ||
210mm | |||
5MHz probe maximum depth: | |||
140mm | 3.5MHz probe maximum depth: | ||
210mm | |||
5MHz probe maximum depth: | |||
140mm | |||
zoom | 3.5MHz probe: x1.0, x1.2, x1.5, x2.0 | ||
selectable as well as depth shift | |||
5MHz probe: x1.0, x1.5, x2.0 | |||
selectable as well as depth shift | 3.5MHz probe: x1.0, x1.2, x1.5, x2.0 | ||
selectable as well as depth shift | |||
5MHz probe: x1.0, x1.5, x2.0 | |||
selectable as well as depth shift | |||
frame rate | the maximum is 40 frame / second | the maximum is 40 frame / second | |
grey scale | 16 | 16 | |
memory | 512 x 512 x 4 bit | 512 x 512 x 4 bit | |
coordinate | |||
transforma- | |||
tion function | monitor can display electronic linear | ||
scanning image or convex sector | |||
scanning image | monitor can display electronic linear | ||
scanning image or convex sector | |||
scanning image | |||
Performance | CTS-310 (SIUI) | EUB-310A (HITACHI) | |
main | |||
unit | video output | PAL or NTSC system TV signal | |
(confirmed in order) | PAL or NTSC system TV signal | ||
(confirmed in order) | |||
power supply | 100V, 110V, 117V, 200V, 220V or | ||
234V, ±10%, 50/60Hz, about | |||
250W | 100V, 110V, 117V, 200V, 220V or | ||
234V, ±10%, 50/60Hz, about | |||
250W | |||
monitor | 9" black and white monitor | 5.5" and 9" black and white monitor | |
volume | |||
and | |||
weight | 395 (W) x 1180 (H) x 728 (L)mm | ||
approx. 65 kg | 405(W) X 710(1) X 1310(h)mm | ||
approx. 40kg | |||
cursor shift | by trackball on keyboard | by joystick on keyboard | |
electric | |||
apparatus | |||
safty | |||
standard | conform to requirement of I class B | ||
type apparatus of IEC 601-1 isolate | |||
resistor testing: testing voltage | |||
1000V L-L, L-G ≥ 10MΩ | conform to requirement of I class B | ||
type apparatus of IEC 601-1 isolate | |||
resistor testing: testing voltage | |||
1000V L-L, L-G≥10MΩ | |||
leakage current: U*-G≤500μA | |||
P-G≤100μA | leakage current: U*-G≤500μA | ||
P-G≤100µA | |||
voltage resistance testing: L-G, P-G | |||
1500V 2mA, no sparking or arcing in | |||
1 minute | |||
work normally when voltage changes | |||
± 10% | voltage resistance testing: L-G, P-G | ||
1500V 2mA, no sparking or arcing in | |||
1 minute | |||
work normally when voltage changes | |||
± 10% | |||
probe ultrasound | linear probe: | linear probe: | |
transmitting | |||
frequency | EZU-PL12 80 elements, | ||
5MHz | |||
scanning width 61mm | |||
EZU-PC3A 80 elements, | |||
40R, 3.5MHz | EZU-PL11 80 elements, 3.5MHz | ||
scanning width 104mm | |||
EZU-PL12 80 elements, 5MHz | |||
3.5MHz scanning angle 60° | scanning width 61mm | ||
EUU-L11S 80 elements, 3.5MHz | |||
scanning width 84mm | |||
convex sector probe: EZU-PC3A 80 | |||
elements, 40R, 3.5MHz, scanning | |||
angle 60° | |||
EZU-PC2A 80 elements, 40R, | |||
5MHz, scanning angle 60° | |||
EUP-V12A 40 elements, 40R, 5MHz, | |||
scanning angle 40° (transvaginal | |||
probe) | |||
operation | temperature 5-40°C, relative | temperature 5-40 °C, relative | |
environment | humidity 30-85% (no water drop) | humidity 30-85% (no water drop) | |
storage environment | temperature -10-60°C, relative | ||
humidity 30-95% (no water drop) air | |||
pressure 700-1060mB | temperature -10-60°C, relative | ||
humidity 30-95% (no water drip) air | |||
pressure 700-1060mB | |||
note |
2
COMPARIS ON LIST OF SIUI PRODUCT AND HITACHI PRODUCT
*U means main unit.
:
3
Public Health Service
Image /page/3/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing right, with flowing lines representing hair or clothing.
MAY 5 1999 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Shantou Institute of Ultrasonic Instruments C/O Robert J. Morton, M.S. President & Certified Radiological Physicist Quality & Regulatory Services 1106 Chiltern Drive Walnut Creek, California 94596
Re: K984161 SIUI CTS-310B Ultrasound Imaging System Dated: April 1, 1999 Received: April 5, 1999 Regulatory Class: II 21 CFR 892.1560/Procode: 90 IYO
Dear Mr. Morton:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the SIUI CTS-310B Ultrasound Imaging System, as described in your premarket notification:
Transducer Model Number
EZU-PL12 EZU-PC3A
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic QS inspections, the FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you may have under sections 531 and 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
Page -2 - Mr. Morton
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
If you have any questions regarding the content of this letter, please contact Rodrigo Perez at (301) 594-1212.
Sincerely yours,
Orind be. Seymon
for
CAPT Daniel B. Sch ltz, M.D. Acting Director Division of Reproductive,
Abdominal, Ear, Nose and Throat, And Radiological Devices Office of Device Evaluation Center for Devices and Radiological Devices
Enclosure(s)
5
Page 2 Re: K984161 SIUI CTS-310B Ultrasound Imaging System
Diagnostic Ultrasound Indications for Use Form Device Name: SIUI CTS-310B
Clinical Application | A | B | M | PWD | CWD | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (specify) |
---|---|---|---|---|---|---|---|---|---|
Ophthalmic | |||||||||
Fetal | N | N | N | ||||||
Abdominal | N | ||||||||
Intraoperative (specify) | |||||||||
Intraoperative | |||||||||
Neurological | |||||||||
Pediatric | N | N | N | ||||||
Small Organ (specify) | N | ||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Cardiac | N | N | N | ||||||
Transesophageal | |||||||||
Transrectal | |||||||||
Transvaginal | |||||||||
Transurethrat | |||||||||
Intravascular | |||||||||
Peripheral Vascular | |||||||||
Laparoscopic | |||||||||
Musculo-skeletal | |||||||||
Conventional | |||||||||
Musculo-skeletal | |||||||||
superficial | |||||||||
Other (specify) |
N=new indication
Additional Comments: thyroid gland, breast, testes____________________________________________________________________________________________________________________________
PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED.
Concurrence of CDRH, office of Device Evaluation (ODE)
Yhrist A. Lezon
(Division Sign-Off)
Prescription Use (Per 21 CFR 801.109)
Division of Reproductive, Abdominal, ENT, and Radiological I
510(k) Number K984110
6
Scanhead Indications for Use Form Device Name: EZU-PL12
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
A | B | M | PWD | CWD | Color | ||||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(specify) | Other | ||||||||||
(specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | N | N | |||||||||
Abdominal | N | ||||||||||
Intraoperative (specify) | |||||||||||
Intraoperative | |||||||||||
Neurological | |||||||||||
Pediatric | N | ||||||||||
Small Organ (specify) | N | ||||||||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Cardiac | |||||||||||
Transesophageal | |||||||||||
Transrectal | |||||||||||
Transvaginal | |||||||||||
Transurethrat | |||||||||||
Intravascular | |||||||||||
Perpheral Vascular | |||||||||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | |||||||||||
Musculo-skeletal | |||||||||||
superficial | |||||||||||
Other (specify) |
N = new indication
Additional Comments: thyroid gland, breast, testes____________________________________________________________________________________________________________________________
..............................................................................................................................................................................
Concurrence of CDRH, office of Device Evaluation (ODE)
am
Prescription Use (Per 21 CFR 801.109)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K984161
7
Scanhead Indications for Use Form Device Name: EZU-PC3A
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
A | B | M | PWD | CWD | Color | ||||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(specify) | Other | ||||||||||
(specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | N | N | N | ||||||||
Abdominal | N | ||||||||||
Intraoperative (specify) | |||||||||||
Intraoperative | |||||||||||
Neurological | |||||||||||
Pediatric | N | N | N | ||||||||
Small Organ (specify) | |||||||||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Cardiac | N | N | N | ||||||||
Transesophageal | |||||||||||
Transrectal | |||||||||||
Transvaginal | |||||||||||
Transurethrat | |||||||||||
Intravascular | |||||||||||
Peripheral Vascular | |||||||||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | |||||||||||
Musculo-skeletal | |||||||||||
superficial | |||||||||||
Other (specify) | |||||||||||
N = new indication | |||||||||||
Additional Comments: |
Concurrence of CDRH, office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K984161
Devices